BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30681722)

  • 1. Expression of ELF1, a lymphoid ETS domain-containing transcription factor, is recurrently lost in classical Hodgkin lymphoma.
    Paczkowska J; Soloch N; Bodnar M; Kiwerska K; Janiszewska J; Vogt J; Domanowska E; Martin-Subero JI; Ammerpohl O; Klapper W; Marszalek A; Siebert R; Giefing M
    Br J Haematol; 2019 Apr; 185(1):79-88. PubMed ID: 30681722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.
    Wurster KD; Hummel F; Richter J; Giefing M; Hartmann S; Hansmann ML; Kreher S; Köchert K; Krappmann D; Klapper W; Hummel M; Wenzel SS; Lenz G; Janz M; Dörken B; Siebert R; Mathas S
    Leukemia; 2017 Mar; 31(3):602-613. PubMed ID: 27538486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.
    Bohle V; Döring C; Hansmann ML; Küppers R
    Leukemia; 2013 Mar; 27(3):671-9. PubMed ID: 23174882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
    Schneider EM; Torlakovic E; Stühler A; Diehl V; Tesch H; Giebel B
    J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma.
    Ushmorov A; Leithäuser F; Sakk O; Weinhaüsel A; Popov SW; Möller P; Wirth T
    Blood; 2006 Mar; 107(6):2493-500. PubMed ID: 16304050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma.
    Hertel CB; Zhou XG; Hamilton-Dutoit SJ; Junker S
    Oncogene; 2002 Jul; 21(32):4908-20. PubMed ID: 12118370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity.
    Giefing M; Winoto-Morbach S; Sosna J; Döring C; Klapper W; Küppers R; Böttcher S; Adam D; Siebert R; Schütze S
    PLoS One; 2013; 8(12):e84928. PubMed ID: 24376854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.
    Schwering I; Bräuninger A; Distler V; Jesdinsky J; Diehl V; Hansmann ML; Rajewsky K; Küppers R
    Mol Med; 2003; 9(3-4):85-95. PubMed ID: 12865944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines.
    Doerr JR; Malone CS; Fike FM; Gordon MS; Soghomonian SV; Thomas RK; Tao Q; Murray PG; Diehl V; Teitell MA; Wall R
    J Mol Biol; 2005 Jul; 350(4):631-40. PubMed ID: 15967459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the CD58 gene in classical Hodgkin lymphoma.
    Schneider M; Schneider S; Zühlke-Jenisch R; Klapper W; Sundström C; Hartmann S; Hansmann ML; Siebert R; Küppers R; Giefing M
    Genes Chromosomes Cancer; 2015 Oct; 54(10):638-45. PubMed ID: 26194173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma.
    Salipante SJ; Adey A; Thomas A; Lee C; Liu YJ; Kumar A; Lewis AP; Wu D; Fromm JR; Shendure J
    Genes Chromosomes Cancer; 2016 Mar; 55(3):278-87. PubMed ID: 26650888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas.
    Atayar C; Poppema S; Blokzijl T; Harms G; Boot M; van den Berg A
    Am J Pathol; 2005 Jan; 166(1):127-34. PubMed ID: 15632006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
    Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
    Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis.
    Guan H; Xie L; Wirth T; Ushmorov A
    Oncotarget; 2016 Jun; 7(24):36854-36864. PubMed ID: 27166193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype.
    Ehlers A; Oker E; Bentink S; Lenze D; Stein H; Hummel M
    Leukemia; 2008 Apr; 22(4):835-41. PubMed ID: 18256685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
    Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma.
    Schmidt A; Schmitz R; Giefing M; Martin-Subero JI; Gesk S; Vater I; Massow A; Maggio E; Schneider M; Hansmann ML; Siebert R; Küppers R
    Genes Chromosomes Cancer; 2010 Sep; 49(9):803-9. PubMed ID: 20607853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation.
    Weniger MA; Melzner I; Menz CK; Wegener S; Bucur AJ; Dorsch K; Mattfeldt T; Barth TF; Möller P
    Oncogene; 2006 Apr; 25(18):2679-84. PubMed ID: 16532038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology of Hodgkin lymphoma.
    Weniger MA; Küppers R
    Leukemia; 2021 Apr; 35(4):968-981. PubMed ID: 33686198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
    Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
    J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.